

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.20063732 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.57163971 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.57163971 |
| 4 | DNA deamination (GO:0045006) | 4.26631155 |
| 5 | protein localization to endosome (GO:0036010) | 4.25201120 |
| 6 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.22181844 |
| 7 | neuronal action potential propagation (GO:0019227) | 4.18254326 |
| 8 | response to interferon-alpha (GO:0035455) | 4.16156989 |
| 9 | peptidyl-threonine dephosphorylation (GO:0035970) | 4.07500334 |
| 10 | mature B cell differentiation involved in immune response (GO:0002313) | 3.88940919 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.83331956 |
| 12 | cell adhesion mediated by integrin (GO:0033627) | 3.81988903 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.78560252 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74467314 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.74335092 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 3.73433956 |
| 17 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.71521737 |
| 18 | mature B cell differentiation (GO:0002335) | 3.67947853 |
| 19 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.61276418 |
| 20 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.61276418 |
| 21 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.58034659 |
| 22 | positive regulation of protein export from nucleus (GO:0046827) | 3.55775512 |
| 23 | negative regulation of type 2 immune response (GO:0002829) | 3.39529667 |
| 24 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.34373687 |
| 25 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.32641823 |
| 26 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.30914580 |
| 27 | mast cell activation (GO:0045576) | 3.30532512 |
| 28 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.29158596 |
| 29 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.28608102 |
| 30 | lymphoid progenitor cell differentiation (GO:0002320) | 3.27737319 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.25362139 |
| 32 | cellular response to zinc ion (GO:0071294) | 3.22458426 |
| 33 | response to interferon-beta (GO:0035456) | 3.21973659 |
| 34 | COPI coating of Golgi vesicle (GO:0048205) | 3.21343141 |
| 35 | Golgi transport vesicle coating (GO:0048200) | 3.21343141 |
| 36 | facial nerve structural organization (GO:0021612) | 3.20865911 |
| 37 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.19454406 |
| 38 | endosome to pigment granule transport (GO:0043485) | 3.18897773 |
| 39 | endosome to melanosome transport (GO:0035646) | 3.18897773 |
| 40 | definitive hemopoiesis (GO:0060216) | 3.18079659 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.17633142 |
| 42 | hypotonic response (GO:0006971) | 3.16142024 |
| 43 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.13618993 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 3.13546360 |
| 45 | necroptotic process (GO:0070266) | 3.13045965 |
| 46 | negative regulation of granulocyte differentiation (GO:0030853) | 3.11614911 |
| 47 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.08689909 |
| 48 | GDP-mannose metabolic process (GO:0019673) | 3.08608999 |
| 49 | COPII vesicle coating (GO:0048208) | 3.08331495 |
| 50 | skin morphogenesis (GO:0043589) | 3.02959038 |
| 51 | cytokine production involved in immune response (GO:0002367) | 3.02584192 |
| 52 | barbed-end actin filament capping (GO:0051016) | 3.01954661 |
| 53 | heparin biosynthetic process (GO:0030210) | 3.01868158 |
| 54 | heparin metabolic process (GO:0030202) | 3.01868158 |
| 55 | myeloid dendritic cell activation (GO:0001773) | 3.01589438 |
| 56 | regulation of early endosome to late endosome transport (GO:2000641) | 2.99982527 |
| 57 | regulation of B cell differentiation (GO:0045577) | 2.99929225 |
| 58 | myeloid dendritic cell differentiation (GO:0043011) | 2.98927774 |
| 59 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.98080211 |
| 60 | Peyers patch development (GO:0048541) | 2.96424493 |
| 61 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.96424493 |
| 62 | B cell mediated immunity (GO:0019724) | 2.95300944 |
| 63 | hemidesmosome assembly (GO:0031581) | 2.90786347 |
| 64 | respiratory chain complex IV assembly (GO:0008535) | 2.90427760 |
| 65 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.89345783 |
| 66 | desmosome organization (GO:0002934) | 2.88255883 |
| 67 | cellular response to interferon-beta (GO:0035458) | 2.87124909 |
| 68 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.86555913 |
| 69 | defense response to protozoan (GO:0042832) | 2.83903030 |
| 70 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.83402758 |
| 71 | interferon-gamma production (GO:0032609) | 2.83038601 |
| 72 | mast cell activation involved in immune response (GO:0002279) | 2.83035150 |
| 73 | mast cell degranulation (GO:0043303) | 2.83035150 |
| 74 | regulation of ARF protein signal transduction (GO:0032012) | 2.82959384 |
| 75 | glutamate secretion (GO:0014047) | 2.82653827 |
| 76 | telomere maintenance via recombination (GO:0000722) | 2.81748960 |
| 77 | platelet dense granule organization (GO:0060155) | 2.81428004 |
| 78 | positive regulation of macrophage differentiation (GO:0045651) | 2.80122849 |
| 79 | iron ion import (GO:0097286) | 2.79636831 |
| 80 | cell-substrate junction assembly (GO:0007044) | 2.76831802 |
| 81 | cortical actin cytoskeleton organization (GO:0030866) | 2.76161486 |
| 82 | response to protozoan (GO:0001562) | 2.75743174 |
| 83 | execution phase of apoptosis (GO:0097194) | 2.74992590 |
| 84 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.74739032 |
| 85 | negative regulation of metanephros development (GO:0072217) | 2.74224717 |
| 86 | sodium ion export (GO:0071436) | 2.72762542 |
| 87 | L-fucose catabolic process (GO:0042355) | 2.72349792 |
| 88 | fucose catabolic process (GO:0019317) | 2.72349792 |
| 89 | L-fucose metabolic process (GO:0042354) | 2.72349792 |
| 90 | response to interleukin-15 (GO:0070672) | 2.72062405 |
| 91 | vesicle coating (GO:0006901) | 2.70779242 |
| 92 | type I interferon signaling pathway (GO:0060337) | 2.70472037 |
| 93 | cellular response to type I interferon (GO:0071357) | 2.70472037 |
| 94 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.69865454 |
| 95 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.69223984 |
| 96 | response to type I interferon (GO:0034340) | 2.68524927 |
| 97 | regulation of regulatory T cell differentiation (GO:0045589) | 2.68210013 |
| 98 | cellular response to ethanol (GO:0071361) | 2.68040761 |
| 99 | embryonic process involved in female pregnancy (GO:0060136) | 2.67169560 |
| 100 | lymph node development (GO:0048535) | 2.66894345 |
| 101 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65277792 |
| 102 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.64678828 |
| 103 | B cell receptor signaling pathway (GO:0050853) | 2.64573194 |
| 104 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64560056 |
| 105 | positive regulation of receptor recycling (GO:0001921) | 2.64443704 |
| 106 | membrane raft organization (GO:0031579) | 2.63728922 |
| 107 | phospholipid scrambling (GO:0017121) | 2.63486171 |
| 108 | T cell homeostasis (GO:0043029) | 2.62872051 |
| 109 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.62578716 |
| 110 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.62331606 |
| 111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.62088379 |
| 112 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.61682115 |
| 113 | membrane invagination (GO:0010324) | 2.60982417 |
| 114 | actin nucleation (GO:0045010) | 2.60295648 |
| 115 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.59511042 |
| 116 | programmed necrotic cell death (GO:0097300) | 2.58655564 |
| 117 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.58253062 |
| 118 | dendritic cell differentiation (GO:0097028) | 2.58067483 |
| 119 | regulation of erythrocyte differentiation (GO:0045646) | 2.57885699 |
| 120 | synaptic vesicle exocytosis (GO:0016079) | 2.56768215 |
| 121 | macroautophagy (GO:0016236) | 2.56077289 |
| 122 | myeloid leukocyte mediated immunity (GO:0002444) | 2.54704655 |
| 123 | viral transcription (GO:0019083) | 2.53388755 |
| 124 | DNA replication initiation (GO:0006270) | 2.53209734 |
| 125 | positive regulation of lamellipodium assembly (GO:0010592) | 2.52222989 |
| 126 | inositol phosphate dephosphorylation (GO:0046855) | 2.50428283 |
| 127 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.50428283 |
| 128 | cellular potassium ion homeostasis (GO:0030007) | 2.49385787 |
| 129 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.48730447 |
| 130 | B cell activation involved in immune response (GO:0002312) | 2.48680331 |
| 131 | stress fiber assembly (GO:0043149) | 2.46950244 |
| 132 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.44216371 |
| 133 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.44124772 |
| 134 | negative regulation of fatty acid transport (GO:2000192) | 2.42768643 |
| 135 | focal adhesion assembly (GO:0048041) | 2.42290755 |
| 136 | cell-substrate adherens junction assembly (GO:0007045) | 2.42290755 |
| 137 | positive regulation of fibroblast migration (GO:0010763) | 2.40051738 |
| 138 | apoptotic cell clearance (GO:0043277) | 2.38901350 |
| 139 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.36780673 |
| 140 | activation of Rac GTPase activity (GO:0032863) | 2.34369225 |
| 141 | regulation of cholesterol homeostasis (GO:2000188) | 2.33878126 |
| 142 | cortical cytoskeleton organization (GO:0030865) | 2.33405705 |
| 143 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.32430120 |
| 144 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.31500061 |
| 145 | adherens junction assembly (GO:0034333) | 2.30684447 |
| 146 | oligosaccharide catabolic process (GO:0009313) | 2.29616498 |
| 147 | positive regulation of Rap GTPase activity (GO:0032854) | 2.29036071 |
| 148 | mammary gland epithelial cell proliferation (GO:0033598) | 2.28075648 |
| 149 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.25787304 |
| 150 | response to laminar fluid shear stress (GO:0034616) | 2.25745728 |
| 151 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.23193683 |
| 152 | positive regulation of extracellular matrix organization (GO:1903055) | 2.21833063 |
| 153 | regulation of protein localization to plasma membrane (GO:1903076) | 2.20921669 |
| 154 | regulation of extracellular matrix disassembly (GO:0010715) | 2.20024808 |
| 155 | detection of molecule of bacterial origin (GO:0032490) | 2.19732564 |
| 156 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.19264813 |
| 157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.17325276 |
| 158 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.17271041 |
| 159 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.17267745 |
| 160 | endocytic recycling (GO:0032456) | 2.16584263 |
| 161 | regulation of macrophage chemotaxis (GO:0010758) | 2.16220314 |
| 162 | import into cell (GO:0098657) | 2.15997433 |
| 163 | synaptic vesicle maturation (GO:0016188) | 2.15879840 |
| 164 | clathrin coat assembly (GO:0048268) | 2.13960603 |
| 165 | protein retention in ER lumen (GO:0006621) | 2.13686188 |
| 166 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.13156460 |
| 167 | response to thyroid hormone (GO:0097066) | 2.12516645 |
| 168 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.12482544 |
| 169 | negative regulation of anoikis (GO:2000811) | 2.11865109 |
| 170 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.11343336 |
| 171 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.09663037 |
| 172 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.09203059 |
| 173 | positive regulation of macroautophagy (GO:0016239) | 2.08131336 |
| 174 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.07746161 |
| 175 | glycosphingolipid catabolic process (GO:0046479) | 2.07635358 |
| 176 | positive regulation of macrophage cytokine production (GO:0060907) | 2.07143402 |
| 177 | Rap protein signal transduction (GO:0032486) | 2.06942094 |
| 178 | surfactant homeostasis (GO:0043129) | 2.06884658 |
| 179 | cellular response to vitamin D (GO:0071305) | 2.04233335 |
| 180 | epithelial cell-cell adhesion (GO:0090136) | 2.03315306 |
| 181 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.01868071 |
| 182 | establishment of endothelial barrier (GO:0061028) | 2.00538342 |
| 183 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 1.99772723 |
| 184 | membrane protein ectodomain proteolysis (GO:0006509) | 1.99025832 |
| 185 | endodermal cell differentiation (GO:0035987) | 1.98894249 |
| 186 | negative regulation of dendrite morphogenesis (GO:0050774) | 1.98002338 |
| 187 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 1.96459321 |
| 188 | peptidyl-threonine modification (GO:0018210) | 1.96320258 |
| 189 | regulation of Rac protein signal transduction (GO:0035020) | 1.96115933 |
| 190 | regulation of anoikis (GO:2000209) | 1.95186396 |
| 191 | Golgi to plasma membrane protein transport (GO:0043001) | 1.95112191 |
| 192 | regulation of receptor recycling (GO:0001919) | 1.94739387 |
| 193 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.93701368 |
| 194 | phospholipid translocation (GO:0045332) | 1.93582813 |
| 195 | lipid translocation (GO:0034204) | 1.93582813 |
| 196 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 1.92758125 |
| 197 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.92537714 |
| 198 | negative regulation of lipid transport (GO:0032369) | 1.92171577 |
| 199 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 1.91681694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.91960202 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.33342743 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.15420700 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.93338948 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.70355089 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.67047878 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.54567349 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.42004274 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.39694487 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.39083587 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.33429576 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.24598986 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 3.18825398 |
| 14 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.09643451 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.88453112 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.69194556 |
| 17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.55662309 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.54085368 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.49143496 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.49060524 |
| 21 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44074283 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.43341386 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43304170 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.37489729 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36985370 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.36448303 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.35910124 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.35296844 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32085080 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27914604 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.25753850 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.19898474 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19847219 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.18851482 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17853132 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16040723 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15443661 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.14925835 |
| 39 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.12049166 |
| 40 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07188834 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.06745810 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.00009782 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.96162955 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94678173 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91487107 |
| 46 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.88437777 |
| 47 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.88437777 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.86102451 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.86074439 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.86070595 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.84863265 |
| 52 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.84332146 |
| 53 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.82486276 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.81031341 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79451815 |
| 56 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.79138805 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.76908078 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74789691 |
| 59 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.69749116 |
| 60 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68346236 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67771791 |
| 62 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.65637682 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.65615147 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.65414782 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.64525976 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62511126 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.61869799 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60998485 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.57583101 |
| 70 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.56652726 |
| 71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56391799 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.55768734 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.55590380 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55071827 |
| 75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52230609 |
| 76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51848541 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50583022 |
| 78 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47766631 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.47143613 |
| 80 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.46814338 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46202690 |
| 82 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.45395512 |
| 83 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.44599265 |
| 84 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41159764 |
| 85 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41159764 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41158755 |
| 87 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40399673 |
| 88 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.39934436 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.39730979 |
| 90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38346492 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38126278 |
| 92 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.37726710 |
| 93 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.36693117 |
| 94 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.35517350 |
| 95 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.35517350 |
| 96 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34854589 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.34568026 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.34317049 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33052340 |
| 100 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32820382 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32668816 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32346445 |
| 103 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31933785 |
| 104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31618875 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30580365 |
| 106 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29515448 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.29334921 |
| 108 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27897299 |
| 109 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27811936 |
| 110 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27338903 |
| 111 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.27051779 |
| 112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26415472 |
| 113 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21381588 |
| 114 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.20775670 |
| 115 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20541585 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19955018 |
| 117 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.19371569 |
| 118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17414121 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14825951 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14239007 |
| 121 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.12982360 |
| 122 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10832836 |
| 123 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.08726912 |
| 124 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08708767 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08539935 |
| 126 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.07678224 |
| 127 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.07427698 |
| 128 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.07176871 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06759280 |
| 130 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05724674 |
| 131 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.05346954 |
| 132 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04945128 |
| 133 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04152235 |
| 134 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01974791 |
| 135 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00314923 |
| 136 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99975092 |
| 137 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97543013 |
| 138 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97429239 |
| 139 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.95834371 |
| 140 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95711100 |
| 141 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95573656 |
| 142 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93570045 |
| 143 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92552144 |
| 144 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91756879 |
| 145 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91358682 |
| 146 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90559218 |
| 147 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90400498 |
| 148 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90153991 |
| 149 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90059896 |
| 150 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89965710 |
| 151 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89859515 |
| 152 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89625472 |
| 153 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88952624 |
| 154 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88862968 |
| 155 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.88773362 |
| 156 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88669050 |
| 157 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88456135 |
| 158 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87392277 |
| 159 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86820078 |
| 160 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.86577456 |
| 161 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.86569497 |
| 162 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.86343412 |
| 163 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84979587 |
| 164 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.83790157 |
| 165 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82328594 |
| 166 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.82143148 |
| 167 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.78260756 |
| 168 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78040051 |
| 169 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77702998 |
| 170 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76027185 |
| 171 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76010591 |
| 172 | MAF_26560356_Chip-Seq_TH2_Human | 0.74896350 |
| 173 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.74080668 |
| 174 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.70954274 |
| 175 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.69794406 |
| 176 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.69577346 |
| 177 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.68697563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.06279383 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.49394950 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.27402191 |
| 4 | MP0010352_gastrointestinal_tract_polyps | 3.11132594 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.10795867 |
| 6 | MP0005174_abnormal_tail_pigmentation | 3.06839593 |
| 7 | MP0001188_hyperpigmentation | 2.91693772 |
| 8 | MP0009379_abnormal_foot_pigmentation | 2.91009624 |
| 9 | MP0005671_abnormal_response_to | 2.88933889 |
| 10 | MP0003566_abnormal_cell_adhesion | 2.79979364 |
| 11 | MP0000685_abnormal_immune_system | 2.75292221 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.64515441 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.57294847 |
| 14 | MP0003646_muscle_fatigue | 2.56286337 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.53901662 |
| 16 | MP0000015_abnormal_ear_pigmentation | 2.49969666 |
| 17 | MP0009785_altered_susceptibility_to | 2.48724943 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.46653561 |
| 19 | MP0001853_heart_inflammation | 2.31788262 |
| 20 | MP0003436_decreased_susceptibility_to | 2.27596197 |
| 21 | MP0003091_abnormal_cell_migration | 2.23119529 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 2.15314220 |
| 23 | MP0005451_abnormal_body_composition | 2.13878382 |
| 24 | MP0002006_tumorigenesis | 2.12778479 |
| 25 | MP0000372_irregular_coat_pigmentation | 2.11970182 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 2.10199312 |
| 27 | MP0003879_abnormal_hair_cell | 2.07780282 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.03952825 |
| 29 | MP0001800_abnormal_humoral_immune | 2.03844615 |
| 30 | MP0005025_abnormal_response_to | 2.02306772 |
| 31 | MP0001819_abnormal_immune_cell | 2.01695386 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.99509316 |
| 33 | MP0003724_increased_susceptibility_to | 1.98903837 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.98771488 |
| 35 | MP0002723_abnormal_immune_serum | 1.96896391 |
| 36 | MP0002398_abnormal_bone_marrow | 1.95716244 |
| 37 | MP0008569_lethality_at_weaning | 1.94605257 |
| 38 | MP0003866_abnormal_defecation | 1.93252754 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.92382504 |
| 40 | MP0003690_abnormal_glial_cell | 1.87914741 |
| 41 | MP0005275_abnormal_skin_tensile | 1.87690117 |
| 42 | MP0000490_abnormal_crypts_of | 1.85493147 |
| 43 | MP0009840_abnormal_foam_cell | 1.82920687 |
| 44 | MP0002095_abnormal_skin_pigmentation | 1.82457822 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.76742817 |
| 46 | MP0002419_abnormal_innate_immunity | 1.74526611 |
| 47 | MP0004510_myositis | 1.65736193 |
| 48 | MP0000716_abnormal_immune_system | 1.63919706 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.63902982 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.63902982 |
| 51 | MP0005387_immune_system_phenotype | 1.63685398 |
| 52 | MP0001790_abnormal_immune_system | 1.63685398 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.59030436 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.58989156 |
| 55 | MP0003329_amyloid_beta_deposits | 1.58345641 |
| 56 | MP0000604_amyloidosis | 1.57651496 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.57103464 |
| 58 | MP0005023_abnormal_wound_healing | 1.56612121 |
| 59 | MP0002638_abnormal_pupillary_reflex | 1.56400563 |
| 60 | MP0001958_emphysema | 1.54515832 |
| 61 | MP0002722_abnormal_immune_system | 1.50468227 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.45619438 |
| 63 | MP0004859_abnormal_synaptic_plasticity | 1.44782298 |
| 64 | MP0003279_aneurysm | 1.44402904 |
| 65 | MP0004272_abnormal_basement_membrane | 1.43866839 |
| 66 | MP0002060_abnormal_skin_morphology | 1.43208040 |
| 67 | MP0003868_abnormal_feces_composition | 1.42635615 |
| 68 | MP0002796_impaired_skin_barrier | 1.41580089 |
| 69 | MP0003045_fibrosis | 1.41417543 |
| 70 | MP0003950_abnormal_plasma_membrane | 1.41116369 |
| 71 | MP0002896_abnormal_bone_mineralization | 1.39931816 |
| 72 | MP0000920_abnormal_myelination | 1.39094717 |
| 73 | MP0010678_abnormal_skin_adnexa | 1.37411868 |
| 74 | MP0002429_abnormal_blood_cell | 1.37126018 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.36506132 |
| 76 | MP0000681_abnormal_thyroid_gland | 1.36388128 |
| 77 | MP0002876_abnormal_thyroid_physiology | 1.33392543 |
| 78 | MP0004147_increased_porphyrin_level | 1.32691290 |
| 79 | MP0004947_skin_inflammation | 1.32254988 |
| 80 | MP0000703_abnormal_thymus_morphology | 1.30858906 |
| 81 | MP0005257_abnormal_intraocular_pressure | 1.30234684 |
| 82 | MP0003880_abnormal_central_pattern | 1.29286304 |
| 83 | MP0004233_abnormal_muscle_weight | 1.27268522 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.27262644 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 1.27053164 |
| 86 | MP0004270_analgesia | 1.26725793 |
| 87 | MP0006082_CNS_inflammation | 1.25138474 |
| 88 | MP0005165_increased_susceptibility_to | 1.24290882 |
| 89 | MP0001845_abnormal_inflammatory_respons | 1.23680326 |
| 90 | MP0003635_abnormal_synaptic_transmissio | 1.22225271 |
| 91 | MP0003448_altered_tumor_morphology | 1.21942080 |
| 92 | MP0003172_abnormal_lysosome_physiology | 1.20969323 |
| 93 | MP0003303_peritoneal_inflammation | 1.19921513 |
| 94 | MP0009046_muscle_twitch | 1.18722798 |
| 95 | MP0005164_abnormal_response_to | 1.17863650 |
| 96 | MP0005076_abnormal_cell_differentiation | 1.17474185 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 1.17307828 |
| 98 | MP0001501_abnormal_sleep_pattern | 1.16593308 |
| 99 | MP0000858_altered_metastatic_potential | 1.16359656 |
| 100 | MP0005409_darkened_coat_color | 1.15929511 |
| 101 | MP0002405_respiratory_system_inflammati | 1.15611333 |
| 102 | MP0001873_stomach_inflammation | 1.15180616 |
| 103 | MP0005166_decreased_susceptibility_to | 1.13309140 |
| 104 | MP0001986_abnormal_taste_sensitivity | 1.12961508 |
| 105 | MP0001851_eye_inflammation | 1.12696065 |
| 106 | MP0005623_abnormal_meninges_morphology | 1.10459477 |
| 107 | MP0000013_abnormal_adipose_tissue | 1.10413350 |
| 108 | MP0001849_ear_inflammation | 1.09298909 |
| 109 | MP0002009_preneoplasia | 1.08628586 |
| 110 | MP0003183_abnormal_peptide_metabolism | 1.08304115 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 1.05340072 |
| 112 | MP0000003_abnormal_adipose_tissue | 1.05017419 |
| 113 | MP0004036_abnormal_muscle_relaxation | 1.03275139 |
| 114 | MP0008260_abnormal_autophagy | 1.02039413 |
| 115 | MP0000569_abnormal_digit_pigmentation | 1.01803744 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.99207399 |
| 117 | MP0008469_abnormal_protein_level | 0.99142064 |
| 118 | MP0001348_abnormal_lacrimal_gland | 0.97865061 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.97852428 |
| 120 | MP0001533_abnormal_skeleton_physiology | 0.96675136 |
| 121 | MP0003959_abnormal_lean_body | 0.95341236 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.94358541 |
| 123 | MP0006292_abnormal_olfactory_placode | 0.94185502 |
| 124 | MP0008007_abnormal_cellular_replicative | 0.93961939 |
| 125 | MP0002272_abnormal_nervous_system | 0.93863417 |
| 126 | MP0009745_abnormal_behavioral_response | 0.92198605 |
| 127 | MP0003252_abnormal_bile_duct | 0.92132435 |
| 128 | MP0000371_diluted_coat_color | 0.92095803 |
| 129 | MP0003941_abnormal_skin_development | 0.91380769 |
| 130 | MP0005621_abnormal_cell_physiology | 0.89917995 |
| 131 | MP0005365_abnormal_bile_salt | 0.88591203 |
| 132 | MP0002019_abnormal_tumor_incidence | 0.88116516 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.87705673 |
| 134 | MP0001915_intracranial_hemorrhage | 0.87655622 |
| 135 | MP0000747_muscle_weakness | 0.87436988 |
| 136 | MP0010386_abnormal_urinary_bladder | 0.86995698 |
| 137 | MP0000751_myopathy | 0.86941234 |
| 138 | MP0002971_abnormal_brown_adipose | 0.86521242 |
| 139 | MP0002693_abnormal_pancreas_physiology | 0.86507176 |
| 140 | MP0000733_abnormal_muscle_development | 0.85356864 |
| 141 | MP0002933_joint_inflammation | 0.85182753 |
| 142 | MP0008874_decreased_physiological_sensi | 0.84611926 |
| 143 | MP0003300_gastrointestinal_ulcer | 0.84519192 |
| 144 | MP0002067_abnormal_sensory_capabilities | 0.83959108 |
| 145 | MP0000358_abnormal_cell_content/ | 0.82048096 |
| 146 | MP0002909_abnormal_adrenal_gland | 0.81704370 |
| 147 | MP0004264_abnormal_extraembryonic_tissu | 0.81383335 |
| 148 | MP0005058_abnormal_lysosome_morphology | 0.78243520 |
| 149 | MP0004484_altered_response_of | 0.77902278 |
| 150 | MP0004087_abnormal_muscle_fiber | 0.77809465 |
| 151 | MP0000343_altered_response_to | 0.76645803 |
| 152 | MP0002064_seizures | 0.75892851 |
| 153 | MP0001666_abnormal_nutrient_absorption | 0.75766052 |
| 154 | MP0000767_abnormal_smooth_muscle | 0.75593320 |
| 155 | MP0002998_abnormal_bone_remodeling | 0.75273011 |
| 156 | MP0002269_muscular_atrophy | 0.74612854 |
| 157 | MP0001216_abnormal_epidermal_layer | 0.74599988 |
| 158 | MP0000759_abnormal_skeletal_muscle | 0.74211770 |
| 159 | MP0002075_abnormal_coat/hair_pigmentati | 0.73903556 |
| 160 | MP0004130_abnormal_muscle_cell | 0.72326573 |
| 161 | MP0003634_abnormal_glial_cell | 0.71904293 |
| 162 | MP0008004_abnormal_stomach_pH | 0.71160047 |
| 163 | MP0000627_abnormal_mammary_gland | 0.70370834 |
| 164 | MP0002090_abnormal_vision | 0.70200078 |
| 165 | MP0002168_other_aberrant_phenotype | 0.70166895 |
| 166 | MP0004084_abnormal_cardiac_muscle | 0.69894369 |
| 167 | MP0003191_abnormal_cellular_cholesterol | 0.69347866 |
| 168 | MP0001502_abnormal_circadian_rhythm | 0.69077359 |
| 169 | MP0006054_spinal_hemorrhage | 0.68913067 |
| 170 | MP0001944_abnormal_pancreas_morphology | 0.68021120 |
| 171 | MP0003828_pulmonary_edema | 0.67445235 |
| 172 | MP0003633_abnormal_nervous_system | 0.67310105 |
| 173 | MP0003075_altered_response_to | 0.63424941 |
| 174 | MP0010307_abnormal_tumor_latency | 0.60034390 |
| 175 | MP0001968_abnormal_touch/_nociception | 0.59843992 |
| 176 | MP0003693_abnormal_embryo_hatching | 0.59220932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 6.23776070 |
| 2 | Type I transferrin isoform profile (HP:0003642) | 5.89925356 |
| 3 | Hypothermia (HP:0002045) | 5.31398538 |
| 4 | Abnormal glycosylation (HP:0012345) | 4.55822492 |
| 5 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 4.55822492 |
| 6 | Abnormal protein N-linked glycosylation (HP:0012347) | 4.55822492 |
| 7 | Abnormal protein glycosylation (HP:0012346) | 4.55822492 |
| 8 | Thrombocytosis (HP:0001894) | 4.00366635 |
| 9 | Thyroid-stimulating hormone excess (HP:0002925) | 3.65213688 |
| 10 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.58357483 |
| 11 | Severe visual impairment (HP:0001141) | 3.47333554 |
| 12 | Myositis (HP:0100614) | 3.44923624 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44045651 |
| 14 | Osteolytic defects of the hand bones (HP:0009699) | 3.37563649 |
| 15 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.37563649 |
| 16 | Focal motor seizures (HP:0011153) | 3.31075177 |
| 17 | Chronic otitis media (HP:0000389) | 3.21666051 |
| 18 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.10714305 |
| 19 | Ankle contracture (HP:0006466) | 3.07958620 |
| 20 | Cortical visual impairment (HP:0100704) | 2.99886778 |
| 21 | Arterial tortuosity (HP:0005116) | 2.93829673 |
| 22 | Premature rupture of membranes (HP:0001788) | 2.91275310 |
| 23 | Recurrent bronchitis (HP:0002837) | 2.83681174 |
| 24 | Gaze-evoked nystagmus (HP:0000640) | 2.83664599 |
| 25 | IgM deficiency (HP:0002850) | 2.82826758 |
| 26 | Vascular tortuosity (HP:0004948) | 2.80517599 |
| 27 | Nonprogressive disorder (HP:0003680) | 2.80155152 |
| 28 | Horizontal nystagmus (HP:0000666) | 2.79472087 |
| 29 | Mitral stenosis (HP:0001718) | 2.77861846 |
| 30 | Protrusio acetabuli (HP:0003179) | 2.77838896 |
| 31 | Aplastic anemia (HP:0001915) | 2.75739358 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 2.74783136 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.74783136 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.74783136 |
| 35 | Albinism (HP:0001022) | 2.69741992 |
| 36 | Neurofibrillary tangles (HP:0002185) | 2.69535056 |
| 37 | Thoracic kyphosis (HP:0002942) | 2.69312281 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.67386656 |
| 39 | Meningitis (HP:0001287) | 2.65523702 |
| 40 | Attenuation of retinal blood vessels (HP:0007843) | 2.65425506 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 2.62785204 |
| 42 | Stomatitis (HP:0010280) | 2.62614148 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.61340916 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.58604096 |
| 45 | Febrile seizures (HP:0002373) | 2.58493161 |
| 46 | Visual hallucinations (HP:0002367) | 2.57871768 |
| 47 | Spinal canal stenosis (HP:0003416) | 2.55827042 |
| 48 | Abnormal number of erythroid precursors (HP:0012131) | 2.51649622 |
| 49 | Aortic aneurysm (HP:0004942) | 2.45564685 |
| 50 | Lower limb hyperreflexia (HP:0002395) | 2.45108497 |
| 51 | Papilledema (HP:0001085) | 2.41298871 |
| 52 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.40860724 |
| 53 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.40834199 |
| 54 | Recurrent abscess formation (HP:0002722) | 2.39112870 |
| 55 | Nasal polyposis (HP:0100582) | 2.35461923 |
| 56 | Type 2 muscle fiber atrophy (HP:0003554) | 2.33785468 |
| 57 | Subacute progressive viral hepatitis (HP:0006572) | 2.32997618 |
| 58 | Aortic dissection (HP:0002647) | 2.31217785 |
| 59 | Cerebral aneurysm (HP:0004944) | 2.29587800 |
| 60 | Abnormality of T cells (HP:0002843) | 2.29306832 |
| 61 | Atonic seizures (HP:0010819) | 2.29233722 |
| 62 | Ocular albinism (HP:0001107) | 2.28556619 |
| 63 | Congenital stationary night blindness (HP:0007642) | 2.27487166 |
| 64 | Recurrent viral infections (HP:0004429) | 2.25220204 |
| 65 | Muscle fiber atrophy (HP:0100295) | 2.22930675 |
| 66 | Mucopolysacchariduria (HP:0008155) | 2.22467976 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22467976 |
| 68 | Bundle branch block (HP:0011710) | 2.21477658 |
| 69 | Abnormality of the thoracic spine (HP:0100711) | 2.21353418 |
| 70 | Right ventricular cardiomyopathy (HP:0011663) | 2.20553296 |
| 71 | Limb ataxia (HP:0002070) | 2.17468293 |
| 72 | Hemiplegia (HP:0002301) | 2.17378089 |
| 73 | Type 1 muscle fiber predominance (HP:0003803) | 2.17087023 |
| 74 | Atrophic scars (HP:0001075) | 2.16824870 |
| 75 | Panhypogammaglobulinemia (HP:0003139) | 2.16300729 |
| 76 | Vertebral compression fractures (HP:0002953) | 2.14617328 |
| 77 | Myocardial infarction (HP:0001658) | 2.14331289 |
| 78 | Microcytic anemia (HP:0001935) | 2.14101455 |
| 79 | Broad face (HP:0000283) | 2.14001060 |
| 80 | Abnormality of the nasal mucosa (HP:0000433) | 2.12508623 |
| 81 | Prolonged bleeding time (HP:0003010) | 2.12476912 |
| 82 | Impaired smooth pursuit (HP:0007772) | 2.11544675 |
| 83 | Termporal pattern (HP:0011008) | 2.10519762 |
| 84 | Insidious onset (HP:0003587) | 2.10519762 |
| 85 | Abnormal platelet function (HP:0011869) | 2.08851632 |
| 86 | Impaired platelet aggregation (HP:0003540) | 2.08851632 |
| 87 | Amaurosis fugax (HP:0100576) | 2.06555963 |
| 88 | Tetraparesis (HP:0002273) | 2.06374736 |
| 89 | Distal lower limb muscle weakness (HP:0009053) | 2.05991645 |
| 90 | Hyporeflexia of lower limbs (HP:0002600) | 2.05327600 |
| 91 | Ankyloglossia (HP:0010296) | 2.04754151 |
| 92 | Abnormality of B cell number (HP:0010975) | 2.03938351 |
| 93 | B lymphocytopenia (HP:0010976) | 2.03938351 |
| 94 | Dysostosis multiplex (HP:0000943) | 2.03466251 |
| 95 | Spondylolisthesis (HP:0003302) | 2.02566457 |
| 96 | Iris hypopigmentation (HP:0007730) | 2.02048059 |
| 97 | Increased connective tissue (HP:0009025) | 2.01008974 |
| 98 | Abnormality of the prostate (HP:0008775) | 2.00822829 |
| 99 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00775418 |
| 100 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00775418 |
| 101 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00775418 |
| 102 | Syringomyelia (HP:0003396) | 2.00404901 |
| 103 | Spinal cord lesions (HP:0100561) | 2.00404901 |
| 104 | Dysmetric saccades (HP:0000641) | 1.98678127 |
| 105 | Agnosia (HP:0010524) | 1.98654582 |
| 106 | Increased hepatocellular lipid droplets (HP:0006565) | 1.97967177 |
| 107 | Recurrent fungal infections (HP:0002841) | 1.97020293 |
| 108 | Epistaxis (HP:0000421) | 1.96092956 |
| 109 | Asymmetric septal hypertrophy (HP:0001670) | 1.95589503 |
| 110 | Overgrowth (HP:0001548) | 1.94868033 |
| 111 | Distal lower limb amyotrophy (HP:0008944) | 1.94758621 |
| 112 | Arterial thrombosis (HP:0004420) | 1.94695343 |
| 113 | Nemaline bodies (HP:0003798) | 1.94480016 |
| 114 | Aneurysm (HP:0002617) | 1.93928501 |
| 115 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93858774 |
| 116 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93325567 |
| 117 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93325567 |
| 118 | Absent frontal sinuses (HP:0002688) | 1.93313453 |
| 119 | Supranuclear gaze palsy (HP:0000605) | 1.92964945 |
| 120 | Abnormality of the columella (HP:0009929) | 1.92716713 |
| 121 | Eczematoid dermatitis (HP:0000976) | 1.92390216 |
| 122 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.91802184 |
| 123 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91780720 |
| 124 | Scanning speech (HP:0002168) | 1.91762091 |
| 125 | Abnormality of oral frenula (HP:0000190) | 1.91295998 |
| 126 | Dilatation of the ascending aorta (HP:0005111) | 1.90654895 |
| 127 | Progressive cerebellar ataxia (HP:0002073) | 1.90541799 |
| 128 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.90347968 |
| 129 | Skin nodule (HP:0200036) | 1.89530967 |
| 130 | Hyperpituitarism (HP:0010514) | 1.88936315 |
| 131 | Recurrent bacterial skin infections (HP:0005406) | 1.88834370 |
| 132 | Cardiovascular calcification (HP:0011915) | 1.88681671 |
| 133 | Petechiae (HP:0000967) | 1.87696214 |
| 134 | Wormian bones (HP:0002645) | 1.87463667 |
| 135 | Abnormality of the common coagulation pathway (HP:0010990) | 1.87443290 |
| 136 | Interstitial pulmonary disease (HP:0006530) | 1.87312643 |
| 137 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.86826566 |
| 138 | Agammaglobulinemia (HP:0004432) | 1.86526426 |
| 139 | Poikiloderma (HP:0001029) | 1.86401677 |
| 140 | Exertional dyspnea (HP:0002875) | 1.85965548 |
| 141 | Acute myeloid leukemia (HP:0004808) | 1.85955126 |
| 142 | Chest pain (HP:0100749) | 1.85859540 |
| 143 | Papillary thyroid carcinoma (HP:0002895) | 1.83487662 |
| 144 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.82619840 |
| 145 | Orchitis (HP:0100796) | 1.81693000 |
| 146 | Optic neuritis (HP:0100653) | 1.81521590 |
| 147 | Retrobulbar optic neuritis (HP:0100654) | 1.81521590 |
| 148 | Asymmetry of the thorax (HP:0001555) | 1.81516515 |
| 149 | Chronic sinusitis (HP:0011109) | 1.80924091 |
| 150 | Gastrointestinal inflammation (HP:0004386) | 1.80386146 |
| 151 | Lower limb amyotrophy (HP:0007210) | 1.79916706 |
| 152 | Fragile skin (HP:0001030) | 1.79757462 |
| 153 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79006238 |
| 154 | Obstructive lung disease (HP:0006536) | 1.79006238 |
| 155 | Thin bony cortex (HP:0002753) | 1.78087084 |
| 156 | Absence seizures (HP:0002121) | 1.77670317 |
| 157 | Basal ganglia calcification (HP:0002135) | 1.77102012 |
| 158 | T lymphocytopenia (HP:0005403) | 1.76231662 |
| 159 | IgG deficiency (HP:0004315) | 1.75848678 |
| 160 | Amyloidosis (HP:0011034) | 1.75689896 |
| 161 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.75656013 |
| 162 | Increased cerebral lipofuscin (HP:0011813) | 1.75521772 |
| 163 | Periodontitis (HP:0000704) | 1.74989430 |
| 164 | Hemoptysis (HP:0002105) | 1.74916989 |
| 165 | Annular pancreas (HP:0001734) | 1.74795472 |
| 166 | Muscle fiber inclusion bodies (HP:0100299) | 1.73684646 |
| 167 | Striae distensae (HP:0001065) | 1.72609101 |
| 168 | Cervical subluxation (HP:0003308) | 1.72331725 |
| 169 | Menstrual irregularities (HP:0000858) | 1.71220135 |
| 170 | Hyperparathyroidism (HP:0000843) | 1.71152474 |
| 171 | Axonal loss (HP:0003447) | 1.70641431 |
| 172 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.69425257 |
| 173 | Spinal rigidity (HP:0003306) | 1.68725809 |
| 174 | Obstructive sleep apnea (HP:0002870) | 1.68156072 |
| 175 | Resting tremor (HP:0002322) | 1.68111632 |
| 176 | Short nail (HP:0001799) | 1.67067289 |
| 177 | Bone pain (HP:0002653) | 1.66828788 |
| 178 | Gingivitis (HP:0000230) | 1.66738812 |
| 179 | Apathy (HP:0000741) | 1.66643038 |
| 180 | Abnormality of complement system (HP:0005339) | 1.66495137 |
| 181 | Atrioventricular block (HP:0001678) | 1.64632950 |
| 182 | Vascular calcification (HP:0004934) | 1.63807434 |
| 183 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.61929659 |
| 184 | Flat acetabular roof (HP:0003180) | 1.61216716 |
| 185 | Exercise-induced myalgia (HP:0003738) | 1.59304252 |
| 186 | Conjugated hyperbilirubinemia (HP:0002908) | 1.56973701 |
| 187 | Mitral valve prolapse (HP:0001634) | 1.55285624 |
| 188 | Complement deficiency (HP:0004431) | 1.54353060 |
| 189 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.54072316 |
| 190 | Subaortic stenosis (HP:0001682) | 1.54072316 |
| 191 | Malnutrition (HP:0004395) | 1.53591514 |
| 192 | Loss of speech (HP:0002371) | 1.53071982 |
| 193 | Increased CSF protein (HP:0002922) | 1.51605584 |
| 194 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.50814886 |
| 195 | Micronodular cirrhosis (HP:0001413) | 1.49731341 |
| 196 | Diminished motivation (HP:0000745) | 1.49570912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 6.68056204 |
| 2 | CAMKK2 | 3.99218239 |
| 3 | EIF2AK3 | 3.60547168 |
| 4 | NLK | 3.19661326 |
| 5 | MUSK | 2.89618764 |
| 6 | PRPF4B | 2.81638504 |
| 7 | MST1R | 2.76890720 |
| 8 | NME2 | 2.75639131 |
| 9 | KIT | 2.42229080 |
| 10 | MAP3K12 | 2.41378006 |
| 11 | PDGFRA | 2.41231840 |
| 12 | LATS2 | 2.39712881 |
| 13 | MAP2K7 | 2.38930236 |
| 14 | CDK19 | 2.35110067 |
| 15 | TEC | 2.32821337 |
| 16 | SCYL2 | 2.25787456 |
| 17 | MAP3K2 | 2.18304374 |
| 18 | TTN | 2.13811617 |
| 19 | FLT3 | 2.10609085 |
| 20 | MAP3K9 | 1.98969880 |
| 21 | CAMKK1 | 1.97372263 |
| 22 | NEK9 | 1.89929493 |
| 23 | RIPK4 | 1.87940358 |
| 24 | BMPR2 | 1.87301832 |
| 25 | MAP4K1 | 1.81452668 |
| 26 | FES | 1.78989318 |
| 27 | KSR2 | 1.74808666 |
| 28 | MKNK2 | 1.68814778 |
| 29 | JAK3 | 1.66748815 |
| 30 | FGFR3 | 1.61461550 |
| 31 | MET | 1.61260316 |
| 32 | TRPM7 | 1.60968889 |
| 33 | STK24 | 1.51110357 |
| 34 | FGFR4 | 1.46799996 |
| 35 | TRIB3 | 1.46342749 |
| 36 | ZAP70 | 1.43423299 |
| 37 | TXK | 1.42703479 |
| 38 | CAMK1 | 1.39921815 |
| 39 | TNK2 | 1.39427918 |
| 40 | MAP3K13 | 1.37432628 |
| 41 | NTRK1 | 1.33950922 |
| 42 | BTK | 1.32568492 |
| 43 | ERN1 | 1.28537098 |
| 44 | SIK1 | 1.27870130 |
| 45 | PTK2 | 1.25237140 |
| 46 | LATS1 | 1.18980605 |
| 47 | TYK2 | 1.18241201 |
| 48 | MAP2K3 | 1.17265760 |
| 49 | PDGFRB | 1.16203007 |
| 50 | SGK3 | 1.13321118 |
| 51 | NEK6 | 1.10606907 |
| 52 | IRAK4 | 1.09891065 |
| 53 | PAK6 | 1.09792498 |
| 54 | CDK12 | 1.08775852 |
| 55 | DDR2 | 1.07948560 |
| 56 | MAP3K3 | 1.07187308 |
| 57 | SYK | 1.07100061 |
| 58 | CSF1R | 1.06192237 |
| 59 | ICK | 1.05547802 |
| 60 | WEE1 | 1.03336769 |
| 61 | PAK4 | 1.02212006 |
| 62 | STK38 | 1.02099286 |
| 63 | MAP3K4 | 1.00409233 |
| 64 | KSR1 | 1.00098999 |
| 65 | EPHA2 | 0.99656666 |
| 66 | TBK1 | 0.96358527 |
| 67 | TGFBR2 | 0.94084417 |
| 68 | CDK6 | 0.92663045 |
| 69 | NTRK3 | 0.91892628 |
| 70 | IRAK3 | 0.91846442 |
| 71 | MATK | 0.91778261 |
| 72 | MYLK | 0.90950414 |
| 73 | TESK1 | 0.89597238 |
| 74 | DAPK1 | 0.87628827 |
| 75 | PDPK1 | 0.86933255 |
| 76 | DMPK | 0.86460101 |
| 77 | WNK1 | 0.86148671 |
| 78 | MAP2K4 | 0.85544018 |
| 79 | JAK1 | 0.84697889 |
| 80 | STK38L | 0.84503367 |
| 81 | CDC42BPA | 0.82840010 |
| 82 | DAPK2 | 0.82627257 |
| 83 | IKBKE | 0.80926934 |
| 84 | TAOK2 | 0.80917318 |
| 85 | IKBKB | 0.79194800 |
| 86 | MAP3K6 | 0.78684576 |
| 87 | ACVR1B | 0.77999003 |
| 88 | HIPK2 | 0.77391991 |
| 89 | STK3 | 0.76338401 |
| 90 | PRKG2 | 0.76230287 |
| 91 | MKNK1 | 0.75919149 |
| 92 | LIMK1 | 0.73753946 |
| 93 | PIM2 | 0.73375060 |
| 94 | EPHB1 | 0.72451837 |
| 95 | FER | 0.72434004 |
| 96 | MAP3K1 | 0.69946406 |
| 97 | IRAK2 | 0.68390511 |
| 98 | RPS6KA4 | 0.67835478 |
| 99 | MELK | 0.67441509 |
| 100 | LCK | 0.67359787 |
| 101 | BRSK2 | 0.66782260 |
| 102 | EIF2AK2 | 0.64297049 |
| 103 | RET | 0.63855125 |
| 104 | VRK1 | 0.63428895 |
| 105 | ERBB4 | 0.62034140 |
| 106 | PAK2 | 0.61522465 |
| 107 | LMTK2 | 0.61139148 |
| 108 | MAPK7 | 0.60277364 |
| 109 | ITK | 0.60052395 |
| 110 | CAMK1D | 0.59537161 |
| 111 | MST4 | 0.59254962 |
| 112 | MAP3K5 | 0.58881465 |
| 113 | AKT3 | 0.58745624 |
| 114 | CAMK1G | 0.56601383 |
| 115 | CDC7 | 0.56088947 |
| 116 | ALK | 0.56034839 |
| 117 | MARK2 | 0.55475980 |
| 118 | ROCK2 | 0.55104094 |
| 119 | PIK3CG | 0.54930731 |
| 120 | ERBB3 | 0.54656144 |
| 121 | PDK1 | 0.54056935 |
| 122 | SIK3 | 0.53425072 |
| 123 | LYN | 0.53155050 |
| 124 | MTOR | 0.52709627 |
| 125 | STK16 | 0.52030556 |
| 126 | MAPK12 | 0.51941528 |
| 127 | CAMK2G | 0.51499252 |
| 128 | CAMK2B | 0.51304454 |
| 129 | JAK2 | 0.51252843 |
| 130 | PKN2 | 0.50768472 |
| 131 | CAMK4 | 0.49904184 |
| 132 | NEK1 | 0.49707348 |
| 133 | RAF1 | 0.49602254 |
| 134 | BMX | 0.49371279 |
| 135 | PRKCH | 0.49300551 |
| 136 | PDK4 | 0.47911569 |
| 137 | PDK3 | 0.47911569 |
| 138 | MAPK4 | 0.46252057 |
| 139 | PIM1 | 0.45904923 |
| 140 | PRKD2 | 0.45536884 |
| 141 | GRK7 | 0.44510311 |
| 142 | CDK4 | 0.43989883 |
| 143 | TAOK3 | 0.42124539 |
| 144 | TGFBR1 | 0.41614058 |
| 145 | MINK1 | 0.40250783 |
| 146 | HCK | 0.39701260 |
| 147 | SGK2 | 0.39687505 |
| 148 | MOS | 0.38190305 |
| 149 | CLK1 | 0.37027370 |
| 150 | YES1 | 0.36704402 |
| 151 | ADRBK2 | 0.35906110 |
| 152 | RPS6KB1 | 0.35655251 |
| 153 | MAP3K14 | 0.35582108 |
| 154 | MAP3K11 | 0.35309460 |
| 155 | TLK1 | 0.34914830 |
| 156 | MAP2K6 | 0.34751575 |
| 157 | CCNB1 | 0.34266966 |
| 158 | MAP3K7 | 0.33318601 |
| 159 | CDK8 | 0.29664091 |
| 160 | EEF2K | 0.28855684 |
| 161 | MAPK11 | 0.27752317 |
| 162 | CSK | 0.27219278 |
| 163 | PDK2 | 0.27177277 |
| 164 | ARAF | 0.25503700 |
| 165 | LRRK2 | 0.25399238 |
| 166 | GRK6 | 0.24290992 |
| 167 | RIPK1 | 0.23580560 |
| 168 | MAPKAPK5 | 0.23253191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.07303883 |
| 2 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.55756678 |
| 3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.41245560 |
| 4 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.30366772 |
| 5 | Thyroid cancer_Homo sapiens_hsa05216 | 2.04364858 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.98465157 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.96739062 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.75224890 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 1.68178550 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 1.65407363 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.64954682 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61545611 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51499156 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.47451465 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47231449 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.41726214 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40000279 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39044984 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.36856332 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35381432 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34717487 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.32169029 |
| 23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.30031417 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.27676403 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26875077 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 1.25610134 |
| 27 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.23921187 |
| 28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.23057766 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.23006065 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21036402 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19787867 |
| 32 | Adherens junction_Homo sapiens_hsa04520 | 1.17990136 |
| 33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.17731219 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.17222114 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.16243066 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.14894347 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.14064311 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.12780500 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11556695 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09122578 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08878629 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07297123 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06535182 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05261698 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04100807 |
| 46 | Morphine addiction_Homo sapiens_hsa05032 | 1.03788058 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03658226 |
| 48 | Base excision repair_Homo sapiens_hsa03410 | 1.02601348 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02437931 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01844371 |
| 51 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.99447465 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.99273433 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98288188 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.98048961 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97828843 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97429578 |
| 57 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.96872100 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96775716 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.96385346 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96091466 |
| 61 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.95843600 |
| 62 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.95703239 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94696022 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94688920 |
| 65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94657819 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94588560 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94424413 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93796064 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.93696193 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.93621843 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.93466361 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90669551 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90392451 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.89956058 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.89841473 |
| 76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89762984 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.89719421 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.88778340 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.88335641 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88306983 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.86903398 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.86886546 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85987570 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.85907460 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85725816 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85054413 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.84735974 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84082524 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84028293 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83126756 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82625995 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81602646 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81496737 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80010082 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79729642 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.79708437 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79588773 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79477246 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79193689 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79063132 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.78647383 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.77488343 |
| 103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.77091451 |
| 104 | GABAergic synapse_Homo sapiens_hsa04727 | 0.76380355 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75855959 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75182752 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.74536663 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.74519256 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74209110 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74088647 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73635514 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73287340 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72657319 |
| 114 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72582426 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72514267 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72473628 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72344852 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.70298210 |
| 119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69799300 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.69555166 |
| 121 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.69540217 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69276462 |
| 123 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67836859 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.67651094 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67425103 |
| 126 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65794400 |
| 127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65111747 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.63456700 |
| 129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63406693 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | 0.63405164 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62861786 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.61974823 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61268593 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60170667 |
| 135 | Allograft rejection_Homo sapiens_hsa05330 | 0.60143937 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60056324 |
| 137 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60050872 |
| 138 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60025556 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59640633 |
| 140 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59501810 |
| 141 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58827438 |
| 142 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58522312 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57678497 |
| 144 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57387882 |
| 145 | Protein export_Homo sapiens_hsa03060 | 0.57155538 |
| 146 | Legionellosis_Homo sapiens_hsa05134 | 0.56732421 |
| 147 | Gap junction_Homo sapiens_hsa04540 | 0.56682479 |
| 148 | Apoptosis_Homo sapiens_hsa04210 | 0.55531933 |
| 149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55395554 |
| 150 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54991274 |
| 151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53935491 |
| 152 | Purine metabolism_Homo sapiens_hsa00230 | 0.53640533 |
| 153 | Taste transduction_Homo sapiens_hsa04742 | 0.52294283 |
| 154 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50837866 |
| 155 | RNA degradation_Homo sapiens_hsa03018 | 0.50609948 |
| 156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50330058 |
| 157 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50319066 |
| 158 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49621119 |
| 159 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49280539 |
| 160 | Phototransduction_Homo sapiens_hsa04744 | 0.47139144 |

